In June 2024, Sarepta Therapeutics voluntarily paused dosing in its clinical trials of Elevidys—a gene therapy for Duchenne muscular dystrophy—after a patient died during the trial. While details remain limited, the FDA was promptly notified, and Sarepta has acknowledged the “serious safety event” that triggered the halt.
If you’ve been in a car accident in Ohio—whether it happened on a busy Cincinnati street or a rural backroad—it’s important to understand the state’s at-fault insurance rules, minimum coverage requirements, and what to do next.
We use cookies to improve your browsing experience on our website. By closing this banner or interacting with our site, you acknowledge and agree to our privacy policy.